SIBS-Novo Nordisk Translational Research Centre for PreDiabetes, Shanghai Institutes for Biological Sciences, Shanghai, China.
IET Syst Biol. 2012 Feb;6(1):22-33. doi: 10.1049/iet-syb.2010.0052.
Complex diseases are commonly believed to be caused by the breakdown of several correlated genes rather than individual genes. The availability of genome-wide data of high-throughput experiments provides us with new opportunity to explore this hypothesis by analysing the disease-related biomolecular networks, which are expected to bridge genotypes and disease phenotypes and further reveal the biological mechanisms of complex diseases. In this study, the authors review the existing network biology efforts to study complex diseases, such as breast cancer, diabetes and Alzheimer's disease, using high-throughput data and computational tools. Specifically, the authors categorise these existing methods into several classes based on the research topics, that is, disease genes, dysfunctional pathways, network signatures and drug-target networks. The authors also summarise the pros and cons of those methods from both computation and application perspectives, and further discuss research trends and future topics of this promising field.
复杂疾病通常被认为是由几个相关基因的崩溃而不是单个基因引起的。全基因组高通量实验数据的可用性为我们提供了新的机会,通过分析与疾病相关的生物分子网络来探索这一假设,这些网络有望连接基因型和疾病表型,并进一步揭示复杂疾病的生物学机制。在这项研究中,作者综述了使用高通量数据和计算工具研究复杂疾病(如乳腺癌、糖尿病和阿尔茨海默病)的现有网络生物学研究进展。具体而言,作者根据研究主题将这些现有方法分为几类,即疾病基因、功能失调途径、网络特征和药物靶点网络。作者还从计算和应用的角度总结了这些方法的优缺点,并进一步讨论了该领域的研究趋势和未来课题。